KUALA LUMPUR: Duopharma Biotech Bhd
, which reported improved earnings in the second quarter, is optimistic about its outlook for the rest of year on higher public spending in the healthcare sector.
The drugmaker is also working to expand its niche product business.
Duopharma Biotech, on Thursday, announced a net profit of RM14.7mil in the three month ended June 30, compared with RM13.9mil made a year earlier.
